Global Coagulation Factor XI Market Research Report 2023

Report ID: 1969789 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Coagulation Factor XI Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 MR-1007
        1.2.3 IONIS-FXIRx
        1.2.4 EP-7041
        1.2.5 AB-022
        1.2.6 BMS-262084
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Coagulation Factor XI Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Thrombosis
        1.3.3 Bleeding and Clotting Disorders
        1.3.4 Acute Ischemic Stroke
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Coagulation Factor XI Market Perspective (2017-2028)
    2.2 Coagulation Factor XI Growth Trends by Region
        2.2.1 Coagulation Factor XI Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Coagulation Factor XI Historic Market Size by Region (2017-2022)
        2.2.3 Coagulation Factor XI Forecasted Market Size by Region (2023-2028)
    2.3 Coagulation Factor XI Market Dynamics
        2.3.1 Coagulation Factor XI Industry Trends
        2.3.2 Coagulation Factor XI Market Drivers
        2.3.3 Coagulation Factor XI Market Challenges
        2.3.4 Coagulation Factor XI Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Coagulation Factor XI Players by Revenue
        3.1.1 Global Top Coagulation Factor XI Players by Revenue (2017-2022)
        3.1.2 Global Coagulation Factor XI Revenue Market Share by Players (2017-2022)
    3.2 Global Coagulation Factor XI Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Coagulation Factor XI Revenue
    3.4 Global Coagulation Factor XI Market Concentration Ratio
        3.4.1 Global Coagulation Factor XI Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Coagulation Factor XI Revenue in 2021
    3.5 Coagulation Factor XI Key Players Head office and Area Served
    3.6 Key Players Coagulation Factor XI Product Solution and Service
    3.7 Date of Enter into Coagulation Factor XI Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Coagulation Factor XI Breakdown Data by Type
    4.1 Global Coagulation Factor XI Historic Market Size by Type (2017-2022)
    4.2 Global Coagulation Factor XI Forecasted Market Size by Type (2023-2028)
5 Coagulation Factor XI Breakdown Data by Application
    5.1 Global Coagulation Factor XI Historic Market Size by Application (2017-2022)
    5.2 Global Coagulation Factor XI Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Coagulation Factor XI Market Size (2017-2028)
    6.2 North America Coagulation Factor XI Market Size by Country (2017-2022)
    6.3 North America Coagulation Factor XI Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Coagulation Factor XI Market Size (2017-2028)
    7.2 Europe Coagulation Factor XI Market Size by Country (2017-2022)
    7.3 Europe Coagulation Factor XI Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Coagulation Factor XI Market Size (2017-2028)
    8.2 Asia-Pacific Coagulation Factor XI Market Size by Country (2017-2022)
    8.3 Asia-Pacific Coagulation Factor XI Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Coagulation Factor XI Market Size (2017-2028)
    9.2 Latin America Coagulation Factor XI Market Size by Country (2017-2022)
    9.3 Latin America Coagulation Factor XI Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Coagulation Factor XI Market Size (2017-2028)
    10.2 Middle East & Africa Coagulation Factor XI Market Size by Country (2017-2022)
    10.3 Middle East & Africa Coagulation Factor XI Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer AG
        11.1.1 Bayer AG Company Detail
        11.1.2 Bayer AG Business Overview
        11.1.3 Bayer AG Coagulation Factor XI Introduction
        11.1.4 Bayer AG Revenue in Coagulation Factor XI Business (2017-2022)
        11.1.5 Bayer AG Recent Development
    11.2 Bristol-Myers Squibb Company
        11.2.1 Bristol-Myers Squibb Company Company Detail
        11.2.2 Bristol-Myers Squibb Company Business Overview
        11.2.3 Bristol-Myers Squibb Company Coagulation Factor XI Introduction
        11.2.4 Bristol-Myers Squibb Company Revenue in Coagulation Factor XI Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Company Recent Development
    11.3 Cambryn Biologics LLC
        11.3.1 Cambryn Biologics LLC Company Detail
        11.3.2 Cambryn Biologics LLC Business Overview
        11.3.3 Cambryn Biologics LLC Coagulation Factor XI Introduction
        11.3.4 Cambryn Biologics LLC Revenue in Coagulation Factor XI Business (2017-2022)
        11.3.5 Cambryn Biologics LLC Recent Development
    11.4 eXithera Pharmaceuticals, Inc
        11.4.1 eXithera Pharmaceuticals, Inc Company Detail
        11.4.2 eXithera Pharmaceuticals, Inc Business Overview
        11.4.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Introduction
        11.4.4 eXithera Pharmaceuticals, Inc Revenue in Coagulation Factor XI Business (2017-2022)
        11.4.5 eXithera Pharmaceuticals, Inc Recent Development
    11.5 Ionis Pharmaceuticals, Inc.
        11.5.1 Ionis Pharmaceuticals, Inc. Company Detail
        11.5.2 Ionis Pharmaceuticals, Inc. Business Overview
        11.5.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Introduction
        11.5.4 Ionis Pharmaceuticals, Inc. Revenue in Coagulation Factor XI Business (2017-2022)
        11.5.5 Ionis Pharmaceuticals, Inc. Recent Development
    11.6 LegoChem Biosciences, Inc
        11.6.1 LegoChem Biosciences, Inc Company Detail
        11.6.2 LegoChem Biosciences, Inc Business Overview
        11.6.3 LegoChem Biosciences, Inc Coagulation Factor XI Introduction
        11.6.4 LegoChem Biosciences, Inc Revenue in Coagulation Factor XI Business (2017-2022)
        11.6.5 LegoChem Biosciences, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Coagulation Factor XI Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of MR-1007
    Table 3. Key Players of IONIS-FXIRx
    Table 4. Key Players of EP-7041
    Table 5. Key Players of AB-022
    Table 6. Key Players of BMS-262084
    Table 7. Key Players of Others
    Table 8. Global Coagulation Factor XI Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Coagulation Factor XI Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Coagulation Factor XI Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Coagulation Factor XI Market Share by Region (2017-2022)
    Table 12. Global Coagulation Factor XI Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Coagulation Factor XI Market Share by Region (2023-2028)
    Table 14. Coagulation Factor XI Market Trends
    Table 15. Coagulation Factor XI Market Drivers
    Table 16. Coagulation Factor XI Market Challenges
    Table 17. Coagulation Factor XI Market Restraints
    Table 18. Global Coagulation Factor XI Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Coagulation Factor XI Market Share by Players (2017-2022)
    Table 20. Global Top Coagulation Factor XI Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor XI as of 2021)
    Table 21. Ranking of Global Top Coagulation Factor XI Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Coagulation Factor XI Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Coagulation Factor XI Product Solution and Service
    Table 25. Date of Enter into Coagulation Factor XI Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Coagulation Factor XI Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Coagulation Factor XI Revenue Market Share by Type (2017-2022)
    Table 29. Global Coagulation Factor XI Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Coagulation Factor XI Revenue Market Share by Type (2023-2028)
    Table 31. Global Coagulation Factor XI Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Coagulation Factor XI Revenue Market Share by Application (2017-2022)
    Table 33. Global Coagulation Factor XI Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Coagulation Factor XI Revenue Market Share by Application (2023-2028)
    Table 35. North America Coagulation Factor XI Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Coagulation Factor XI Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Coagulation Factor XI Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Coagulation Factor XI Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Coagulation Factor XI Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Coagulation Factor XI Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Coagulation Factor XI Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Coagulation Factor XI Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Coagulation Factor XI Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Coagulation Factor XI Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Bayer AG Company Detail
    Table 46. Bayer AG Business Overview
    Table 47. Bayer AG Coagulation Factor XI Product
    Table 48. Bayer AG Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 49. Bayer AG Recent Development
    Table 50. Bristol-Myers Squibb Company Company Detail
    Table 51. Bristol-Myers Squibb Company Business Overview
    Table 52. Bristol-Myers Squibb Company Coagulation Factor XI Product
    Table 53. Bristol-Myers Squibb Company Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 54. Bristol-Myers Squibb Company Recent Development
    Table 55. Cambryn Biologics LLC Company Detail
    Table 56. Cambryn Biologics LLC Business Overview
    Table 57. Cambryn Biologics LLC Coagulation Factor XI Product
    Table 58. Cambryn Biologics LLC Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 59. Cambryn Biologics LLC Recent Development
    Table 60. eXithera Pharmaceuticals, Inc Company Detail
    Table 61. eXithera Pharmaceuticals, Inc Business Overview
    Table 62. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product
    Table 63. eXithera Pharmaceuticals, Inc Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 64. eXithera Pharmaceuticals, Inc Recent Development
    Table 65. Ionis Pharmaceuticals, Inc. Company Detail
    Table 66. Ionis Pharmaceuticals, Inc. Business Overview
    Table 67. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product
    Table 68. Ionis Pharmaceuticals, Inc. Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 69. Ionis Pharmaceuticals, Inc. Recent Development
    Table 70. LegoChem Biosciences, Inc Company Detail
    Table 71. LegoChem Biosciences, Inc Business Overview
    Table 72. LegoChem Biosciences, Inc Coagulation Factor XI Product
    Table 73. LegoChem Biosciences, Inc Revenue in Coagulation Factor XI Business (2017-2022) & (US$ Million)
    Table 74. LegoChem Biosciences, Inc Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Coagulation Factor XI Market Share by Type: 2021 VS 2028
    Figure 2. MR-1007 Features
    Figure 3. IONIS-FXIRx Features
    Figure 4. EP-7041 Features
    Figure 5. AB-022 Features
    Figure 6. BMS-262084 Features
    Figure 7. Others Features
    Figure 8. Global Coagulation Factor XI Market Share by Application in 2021 & 2028
    Figure 9. Thrombosis Case Studies
    Figure 10. Bleeding and Clotting Disorders Case Studies
    Figure 11. Acute Ischemic Stroke Case Studies
    Figure 12. Others Case Studies
    Figure 13. Coagulation Factor XI Report Years Considered
    Figure 14. Global Coagulation Factor XI Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Coagulation Factor XI Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Coagulation Factor XI Market Share by Region: 2021 VS 2028
    Figure 17. Global Coagulation Factor XI Market Share by Players in 2021
    Figure 18. Global Top Coagulation Factor XI Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor XI as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Coagulation Factor XI Revenue in 2021
    Figure 20. North America Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Coagulation Factor XI Market Share by Country (2017-2028)
    Figure 22. United States Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Coagulation Factor XI Market Share by Country (2017-2028)
    Figure 26. Germany Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Coagulation Factor XI Market Share by Region (2017-2028)
    Figure 34. China Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Coagulation Factor XI Market Share by Country (2017-2028)
    Figure 42. Mexico Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Coagulation Factor XI Market Share by Country (2017-2028)
    Figure 46. Turkey Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Coagulation Factor XI Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Bayer AG Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 49. Bristol-Myers Squibb Company Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 50. Cambryn Biologics LLC Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 51. eXithera Pharmaceuticals, Inc Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 52. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 53. LegoChem Biosciences, Inc Revenue Growth Rate in Coagulation Factor XI Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics LLC
eXithera Pharmaceuticals, Inc
Ionis Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
Frequently Asked Questions
Coagulation Factor XI report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Coagulation Factor XI report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Coagulation Factor XI report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports